XML 51 R37.htm IDEA: XBRL DOCUMENT v3.24.3
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Share-based Compensation, Stock Options and Stock Appreciation Rights Award Activity
The following table presents certain information related to the activity of our non-vested stock option grants:
Number of Stock OptionsWeighted Average Exercise PricesWeighted Average Remaining Contractual Term (years)
Aggregate Intrinsic Value (3)
Outstanding as of December 31, 2023
1,028,760 $3.83 7.80 $6,151,000 
Granted (1)
196,275 4.82 — — 
  Less: Forfeited— — — — 
  Less: Expired— — — — 
Less: Exercised
95,000 2.35 — — 
Outstanding as of September 30, 2024
1,130,035 $4.12 7.47 $8,360,000 
Vested as of September 30, 2024(2)
1,276,019 $4.30 7.04 $6,147,000 
Exercisable as of September 30, 2024
840,768 $4.30 7.04 $6,147,000 
(1) Contingent shares granted during 2023 have been included in the calculation of 2024's granted values.
(2) The vested shares are calculated based on all vested shares at September 30, 2024, inclusive of those that have since expired. The weighted average exercise prices, weighted-average remaining contractual term and aggregate intrinsic value is calculated based on only vested shares that are outstanding and exercisable at September 30, 2024.
(3) Presented in ones.
Schedule of Nonvested Share Activity
The following table presents certain information related to the activity of our non-vested restricted common stock grants:
Number of Restricted SharesWeighted Average Grant Date Fair Value
Outstanding as of December 31, 2023
445,646 $2.64 
Granted (1)
598,713 7.41 
Less: Forfeited1,476 4.56 
Less: Vested 436,472 3.36 
Outstanding as of September 30, 2024
606,411 $6.23 
Share-based Payment Arrangement, Activity
The following table presents our total stock-based compensation expense:
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
Employee stock-based compensation expense
     Pre-tax $556 $350 $1,593 $738 
     Post-tax (1)
439 277 1,258 583 
Director stock-based compensation expense
     Pre-tax 138 60 310 115 
     Post-tax (1)
109 47 245 91 
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions The following weighted-average assumptions were used to value the stock options granted:
20242023
Expected annual dividend yield—  %—  %
Expected volatility86.92  %80.84  %
Risk-free interest rate4.37  %3.44  %
Expected term6 years6 years